Progress in studies on factors affecting antiviral therapy for chronic hepatitis C
10.3760/cma.j.cn112866-20240927-00145
- VernacularTitle:影响慢性丙型肝炎抗病毒治疗因素的研究现状
- Author:
Conghui XU
1
;
Wanting LYU
1
;
Jiahuan GUO
1
;
Zhaozhen LIU
1
;
Can PANG
1
;
Hongyan LU
1
Author Information
1. 北京市疾病预防控制中心 北京市预防医学研究中心，北京 100013
- Publication Type:Journal Article
- Keywords:
Hepatitis C;
Antiviral therapy;
Associated factors
- From:
Chinese Journal of Experimental and Clinical Virology
2024;38(6):717-721
- CountryChina
- Language:Chinese
-
Abstract:
Antiviral therapy is an effective means of curing chronic hepatitis C (CHC) and a key focus of preventing the spread of hepatitis C. By analyzing domestic and foreign literature, this paper provides an overview of the estimation of the antiviral treatment rate for CHC, the current situation of antiviral treatment for CHC both domestically and internationally, and the factors that affect acceptance of antiviral treatment. At present, the antiviral treatment rate for CHC cases is relatively low both domestically and internationally. The treatment status of CHC cases is related to factors such as the general situation of the case, knowing their HCV status or self-perceived condition, concurrent presence of other diseases or conditions, knowledge of hepatitis C prevention and treatment, and social interaction and behavioral guidance. In response to the relevant difficulties, in-depth research or more support is needed to improve the antiviral treatment rate of CHC cases and achieve the goal of eliminating hepatitis C by 2030. Efforts should be made to strengthen policy support, improve the diagnosis of hepatitis C, prevent and control multiple diseases together, conduct targeted publicity and education, and enhance social support.
